Intra-Articular Injection of an Extracellular Vesicle Isolate Product to Treat Shoulder Osteoarthritis in an Athlete
Journal Title: Journal of Regenerative Biology and Medicine - Year 2020, Vol 2, Issue 1
Abstract
Cadaver and radiographic studies have demonstrated shoulder osteoarthritis (OA) in up to 33% of patients over the age of 60 [1]. Patients that present with shoulder OA have pain, crepitus and loss of glenohumeral motion. Limiting the ability to place your hand where you desire severely impairs activities of daily living. The nonsurgical treatments for shoulder OA, include shoulder exercises, the use of analgesics and non-steroidal anti-inflammatory medications. If these non-surgical treatments fail to relieve the OA impairment, the surgical treatment is total shoulder arthroplasty (TSA) [2].
Authors and Affiliations
John Bender, M. D. 1 and Maxwell Dordevic2*
Keywords
Related Articles
- EP ID EP707317
- DOI https://doi.org/10.37191/Mapsci-2582-385X-2(1)-014
- Views 93
- Downloads 0
Therapy on Parkinson’s Disease
Parkinson's disorder (PD) is a central nervous condition that causes tremors and affects mobility. Symptoms appear slowly, generally beginning with a slight shaking in one hand. Tremors are typical, but the disease can a...
The Future of Medicine - Biologics and Artificial Intelligence
The future of medicine is in biologics and artificial intelligence AI. With the advent of advancing and disruptive technologies, many traditional therapies are being replaced by new therapies such as: stem cell therapy,...
The Structure of the Placenta in the Normal Course of Pregnancy and in Fetoplacental Insufficiency
One of the most important problems of modern obstetrics is the prevention of complicated pregnancy and reproductive losses. Normally, after 40 weeks, aging of the placenta is a sign of the onset of labor. But year after...
In Continuously Battling COVID-19 with Innovative Perspectives
In the commentary to a paper issued in J Chem Edu Res Prac 2020, 4(2), 1-4 by Laila Mahmoud Montaser2020 entitled “Could putting the mesenchymal stem cells technology into practice be an optimistic therapy for the critic...
ACE-2-Receptors of the Epidermis, Dermal Vascular Walls and Sebaceous Gland Cells: The Way of COVID-19 Entry into the Body?
Since the outbreak near a fish market in Wuhan, China, in December 2019, researchers have been searching for an effective therapy to control the spreading of the new coronavirus SARS-CoV-2 and inhibit COVID-19 infection....